drugset / Trial / NCT00846287

Assessment of Arformoterol for Chronic Obstructive Pulmonary Disease (COPD) Using Hyperpolarized 3He MRI

NCT00846287

RandomizedParallel-groupQuadruple-blindDiagnostic

Summary

The purpose of this study is to determine efficacy of MR imaging with hyperpolarized helium-3 gas in COPD patients both before and after treatment.

Timeline

Start
2008-11
Primary completion
2011-04
Completion
2011-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Arformoterol Small molecule 15 ug Inhaled